Under construction – not a live service
Sign in
Enrolling by invitationPhase 2/3

Orthobiologic Treatment for Knee Osteoarthritis

Key facts

Where
Tromsø, NorwaySee the site
Phase
Phase 2/3

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 70 years old?

Source: NCT06893250, who can take part

Where in Norway

  • University Hospital in Northern NorwayTromsø, NorwayNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
University Hospital of North Norway
Trial code
NCT06893250
Record updated
15 June 2026
Original description
The goal of this randomized clinical trial is to compare treatment for osteoarthritis in the knee using platelet rich plasma (PRP) or adipose stem cells (ADS). The main questions it aims to answer are:Read full original descriptionShow less

Orthobiologic Treatment for Knee Osteoarthritis (Ortobiologisk Behandling av Kneleddsartrose)

The goal of this randomized clinical trial is to compare treatment for osteoarthritis in the knee using platelet rich plasma (PRP) or adipose stem cells (ADS). The main questions it aims to answer are:

* Will the patients clinically benefit from the treatment, and if so, which treatment is better? * Will there be radiological findings to support this? Participants will be randomized into one of four groups: PRP, ADS, PRP + ADS or placebo treatment (saline) and will be examined and get an X-ray and MRI of the knee taken at inclusion and after 1 and 2 years.

Inclusion: Symptomatic osteoarthritis in the knee grade I-III using the Kellgren-Lawrance Grading Scale; Age 40-70 years; Minimum VAS 3; No use of NSAIDs or steroids the last 14 days; No injections of hyaluronic acid the last three months; Varus/valgus deformity \<5 degrees as evaluated on x-ray imaging.

Exclusion: Previous knee surgery on the affected knee; Previous infection in the knee; Cancer; Other diseases (rheumatoid arthritis, diabetes, systemic diseases or corticosteroid-demaning disease); Patients with a high risk of deep vein thrombosis; Patients who cannot cooperate/are low compliance (psychiatric disease) or has contraindications for MRI; Pregnant or breastfeeding women; Other etiologies of knee pain (refered pain, pain from the back, dislocated meniscus on MRI, osteoarthritis grade IV using the Kellgren-Lawrance Grading Scale); Secondary osteoarthritis in the knee.

ClinicalTrials.gov NCT06893250